Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Virus-infected Cirrhosis”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Testing effectiveness (Phase 2)Study completedNCT01707472
What this trial is testing

Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver Fibrosis

Who this might be right for
Liver FibrosisHepatitis CHIV+1 more
Gilead Sciences 18
Not applicableStudy completedNCT01980290
What this trial is testing

Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis, Chronic
Janssen Pharmaceutica N.V., Belgium 50
Early research (Phase 1)Study completedNCT02259855
What this trial is testing

Pharmacokinetics (PK) of Tipranavir/Ritonavir, Ribavirin, Pegylated Interferon (Peg INF) in Hepatitis C (HCV) Subjects With Mild Hepatic Impairment and in HCV, Hepatitis B (HBV), Hepatitis D Infected Subjects or Alcoholic Cirrhosis With Moderate Hepatic Impairment

Who this might be right for
Hepatic Insufficiency
Boehringer Ingelheim 36
Not applicableStudy completedNCT01355107
What this trial is testing

Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of Disease

Who this might be right for
Hepatitis CLiver CirrhosisCarcinoma, Hepatocellular
University Hospital Freiburg 32
Early research (Phase 1)Study completedNCT01289951
What this trial is testing

Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic Cirrhosis

Who this might be right for
Human Immunodeficiency VirusHepatitis C
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 10
Post-approval studies (Phase 4)Study completedNCT00056862
What this trial is testing

Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3

Who this might be right for
Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 58
Testing effectiveness (Phase 2)Study completedNCT00018031
What this trial is testing

Peginterferon Alpha-2b And Ribavirin to Treat Hepatitis C in HIV-Infected Patients

Who this might be right for
Hepatitis CHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Not applicableStudy completedNCT02785835
What this trial is testing

Hepatocellular Carcinoma in HIV-infected Patients

Who this might be right for
Hepatocellular CarcinomaHIVChronic Hepatitis C+2 more
Hospital Universitario de Valme 477
Not applicableStudy completedNCT02828254
What this trial is testing

A Follow-up Evaluation Study of PRI-724-1101

Who this might be right for
Hepatitis C Virus-infected Cirrhosis
Komagome Hospital 8
Large-scale testing (Phase 3)Study completedNCT02582632
What this trial is testing

Evaluate Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Hepatitis C Virus Genotype 1b-Infected Adults

Who this might be right for
Hepatitis C InfectionHepatitis C Virus
AbbVie 166
Large-scale testing (Phase 3)Study completedNCT02939989
What this trial is testing

Efficacy and Safety of Glecaprevir (ABT-493)/Pibrentasvir (ABT 530) (GLE/PIB) in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie Clinical Study

Who this might be right for
Hepatitis C Virus Infection
AbbVie 33
Post-approval studies (Phase 4)Study completedNCT02128542
What this trial is testing

Efficacy and Safety of Sofosbuvir+Ribavirin in Genotype 2 HCV-infected U.S. Veterans With Cirrhosis

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 66
Large-scale testing (Phase 3)WithdrawnNCT00381017
What this trial is testing

Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371)

Who this might be right for
Hepatitis CLiver CirrhosisHIV Infections
Merck Sharp & Dohme LLC
Testing effectiveness (Phase 2)Study completedNCT03593447
What this trial is testing

To Evaluate Efficacy and Safety in TG-2349 Combination With DAG181 (± Ribavirin) in HCV Genotype I Infected Patients

Who this might be right for
Chronic Hepatics C Virus (HCV) Genotype 1Non-CirrhoticCirrhosis+1 more
Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd. 133
Large-scale testing (Phase 3)Ended earlyNCT00811967
What this trial is testing

Inhibition of Disease Progression in Hepatitis C-infected Patients With Compensated Liver Cirrhosis (P03811) (COMPLETED)

Who this might be right for
Hepatitis C, ChronicLiver Cirrhosis
Merck Sharp & Dohme LLC 50
Not applicableStudy completedNCT01908660
What this trial is testing

Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions

Who this might be right for
Human Immunodeficiency VirusHepatitis B, ChronicHepatitis C, Chronic
Valme University Hospital 192
Early research (Phase 1)Study completedNCT00896233
What this trial is testing

Magnetic Resonance Elastography for Assessment of Liver Fibrosis (MK-0000-132)(COMPLETED)

Who this might be right for
Liver FibrosisHepatitis C Virus
Merck Sharp & Dohme LLC 10
Large-scale testing (Phase 3)Study completedNCT04155515
What this trial is testing

A Phase III Study to Evaluate Efficacy and Safety of TG-2349 in Combination With DAG181 and RBV for HCV Type I Patients

Who this might be right for
Chronic Hepatics C Virus (HCV) Genotype 1Non-CirrhoticCirrhosis+1 more
Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd. 370
Testing effectiveness (Phase 2)Study completedNCT01636778
What this trial is testing

Japanese Phase II Study of SB-497115-GR in Hepatitis C Virus Infected Patients

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 45
Large-scale testing (Phase 3)UnknownNCT02961426
What this trial is testing

Strategic Transformation of the Market of HCV Treatments

Who this might be right for
Hepatitis C
Drugs for Neglected Diseases 603
Load More Results